ES71
TEAS SECTION 71 RECEIVED
07/15/2026
Back to search
Official data from USPTO
PENTAPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/15/2026
Classification
Registered
Trademark type
Combined
Nice classes
1, 5
Filing date
03/21/2005
Registration date
07/25/2006
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2016
Last transaction
07/15/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CH
Examiner
TANNER, MICHAEL R
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Pentapharm AG
DSM IP Assets B.V.
PENTAPHARM AG (PENTAPHARM Ltd)
Representatives
Joshua B. Brady Nixon & Vanderhye PC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for the pharmaceuticalpharmaco-cosmetic and diet foodstuff industriesnamely chemical additives for use in the manufacture of foodpharmaceuticalscosmeticschemicals for use in the manufacture of cosmeticschemical agents used in the manufacture of beauty care products and skin care products; biochemical preparations for the pharmaceuticalpharmo-cosmetic and diet foodstuff industrieshaemostatic assays for use in industrial and scientific purposescatalysts for chemical and biochemical processesbotanical extracts for use in making cosmetics; diagnostic preparationsdiagnostic preparations for scientific or research usediagnostic reagents for scientific or research use
Class 5
Chemical preparations for medico-scientific purposeschemical reagents for medical purposes; pharmaceutical preparations for use in dermatology; diagnostic preparations for medical usediagnostic preparations to measure blood coagulations; diagnostic preparations for clinical or medical laboratory use
Publications
History of USPTO decisions and trademark events.
45 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/25/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/25/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/07/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/12/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/28/2016
71AG
REGISTERED-SEC.71 ACCEPTED
07/28/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/25/2016
ES71
TEAS SECTION 71 RECEIVED
06/17/2016
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/25/2015
CORV
REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
12/27/2012
PAPER RECEIVED
12/17/2012
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/13/2012
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
12/13/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/13/2012
715F
REGISTERED - SEC. 71 & SEC. 15 FILED
11/16/2012
ES75
TEAS SECTION 71 & 15 RECEIVED
11/16/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/18/2008
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/17/2008
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/27/2008
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/25/2007
FIMP
FINAL DISPOSITION PROCESSED
03/25/2007
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/23/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
07/25/2006
PUBO
PUBLISHED FOR OPPOSITION
05/02/2006
NPUB
NOTICE OF PUBLICATION
04/12/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/13/2006
ALIE
ASSIGNED TO LIE
02/24/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2006
XAEC
EXAMINER'S AMENDMENT ENTERED
02/21/2006
GNEA
EXAMINERS AMENDMENT E-MAILED
02/21/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/21/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/17/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2006
RFNT
REFUSAL PROCESSED BY IB
11/04/2005
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/18/2005
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/17/2005
CNRT
NON-FINAL ACTION WRITTEN
10/17/2005
DOCK
ASSIGNED TO EXAMINER
10/12/2005
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/05/2005
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/05/2005
NWAP
NEW APPLICATION ENTERED
06/17/2005
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
06/16/2005
Continuous trademark protection
Get notified about every new filing that threatens PENTAPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.